Prof. Dr. med. Christian la Fougère
Director and Chair
Department of Nuclear Medicine and Clinical Molecular Imaging
University Hospital Tübingen
Otfried-Müller Str. 14
72076 Tübingen, Germany
Phone: +49 (0)7071 29 86553
Fax: +49 (0)7071-29-4601
Molecular imaging (MI) is paving the way for precision and personalized medicine. Molecular imaging techniques using radiolabeled pharmaceuticals and positron-emission-tomography (PET) are increasingly used for the assessment of pathobiochemical and pathophysiological changes in oncology and neurology. We aim to test and to implement new molecular imaging probes for different oncological and neurological diseases, in order to obtain a better characterization of the underlying molecular changes in vivo.
New generation hybrid PET-MR scanner enable the simultaneous acquisition of molecular (PET) as well as morphological and functional (chemical shifts, flow, diffusion, blood oxygenation and perfusion) changes (MR) in vivo, that might give new insights in the oncological processes. We aim to use those multi-parametric imaging techniques in order to provide an insight in physiological (adaptive) as well as pathophysiological changes, which might lead to an individualized treatment stratification for our patients in the future.
Joint Research Projects
2017 – 2020
Else-Kröner-Fresenius-Forschungskolleg “Therapieresistenz solider Tumore“